Aiolos Bio: GSK snaps up potential asthma treatment gamechanger in 800m deal
GSK has completed the acquisition of Aiolos Bio, a company working on treatments for respiratory and inflammatory conditions.
Read full article »
Aiolos Bio is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for respiratory and inflammatory diseases.
Read more